UNH vs ELV
UNH and ELV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | ELVELEVANCE HEALTH, INC. |
|---|---|---|
| Market cap | $340.13B | $90.77B |
| P/E (TTM) | 24.4 | 18.5 |
| P/B | 10.30 | 2.02 |
| P/S | 0.8x | 0.5x |
| Dividend yield | 2.33% | 1.68% |
| Revenue | $450.13B(TTM) | $201.11B(TTM) |
| Revenue growth (YoY) | 11.8% | 12.5% |
| Net income | $14.12B(TTM) | $4.96B(TTM) |
| Earnings growth (YoY) | -16.3% | -5.3% |
| EPS, diluted | $15.56(TTM) | $22.61(TTM) |
| EBIT margin | 4.2% | 3.6% |
| ROE | 36.5% | 12.6% |
| ROIC | 21.3% | 9.3% |
| 1y total return | +13.9% | +37.4% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: UNH vs ELV
| Metric | UNH | ELV |
|---|---|---|
| End value | $35.0K | $35.8K |
| Total return | +249.9% | +258.3% |
| CAGR | +12.9% | +13.1% |
| Volatility | 29.9% | 31.0% |
| Sharpe | 0.42 | 0.42 |
| Sortino | 0.58 | 0.60 |
| Max drawdown | -61.4% | -50.4% |
Based on 2600 common trading days, 2016-05-13 → 2026-09-16 · risk-free 4.11% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)